Home/Carina Biotech/Dr. Deborah Rathjen
DD

Dr. Deborah Rathjen

Chief Executive Officer & Managing Director

Carina Biotech

Therapeutic Areas

Carina Biotech Pipeline

DrugIndicationPhase
CAR-T Solid Tumor ProgramSolid TumorsPhase 1/2a